🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

36,04 USD

Máx. histórico

41,81

55 días

Caída desde máximo

-13,80%

Rango 52 semanas

19,32 – 42,50

Variación hoy

+0,42%

Cierre anterior

35,89

Rango de hoy

35,56 – 36,78

Volumen hoy

6.686.435

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,48%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 10 horas
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/05/2023 9,23 9,23 8,53 8,74 -4,48% 7,58% 2.662.700
15/05/2023 9,11 9,27 8,72 9,15 +0,44% 6,02% 1.999.100
12/05/2023 9,10 9,18 9,02 9,11 +0,66% 1,76% 1.302.800
11/05/2023 9,24 9,24 8,80 9,05 -1,95% 4,76% 2.686.800
10/05/2023 9,39 9,49 9,09 9,23 -1,49% 4,24% 2.943.100
09/05/2023 8,98 9,50 8,79 9,37 +4,58% 7,91% 5.608.300
08/05/2023 8,65 9,00 8,45 8,96 +3,94% 6,36% 3.870.000
05/05/2023 8,39 8,80 8,39 8,62 +2,62% 4,89% 2.497.600
04/05/2023 8,42 8,50 8,06 8,40 -0,47% 5,17% 3.414.500
03/05/2023 8,24 8,55 8,06 8,44 +2,80% 5,95% 3.155.800
02/05/2023 8,45 8,61 8,07 8,21 -4,76% 6,39% 2.951.200
01/05/2023 8,55 8,72 8,43 8,62 +0,82% 3,39% 1.661.800
28/04/2023 8,34 8,62 8,26 8,55 +1,42% 4,26% 1.765.500
27/04/2023 8,66 8,66 8,41 8,43 -2,43% 2,94% 2.401.100
26/04/2023 8,84 8,87 8,57 8,64 -1,14% 3,39% 2.050.200
25/04/2023 8,70 8,90 8,60 8,74 -1,47% 3,45% 1.798.200
24/04/2023 8,98 8,99 8,73 8,87 -1,00% 2,90% 1.609.900
21/04/2023 8,85 8,98 8,60 8,96 +1,82% 4,35% 2.596.500
20/04/2023 8,75 8,94 8,55 8,80 +0,00% 4,46% 2.768.600
19/04/2023 8,90 8,97 8,47 8,80 -0,79% 5,62% 3.051.400
18/04/2023 8,49 8,95 8,15 8,87 +4,11% 9,42% 6.509.300
17/04/2023 7,84 8,58 7,60 8,52 +19,83% 12,50% 13.555.800
14/04/2023 7,56 7,56 7,01 7,11 -6,45% 7,28% 1.814.000
13/04/2023 7,42 7,76 7,42 7,60 +2,56% 4,51% 2.656.300
12/04/2023 7,47 7,63 7,36 7,41 -0,27% 3,68% 1.244.200
11/04/2023 7,37 7,55 7,36 7,43 +0,68% 2,51% 1.207.300
10/04/2023 7,39 7,46 7,24 7,38 +0,00% 2,91% 1.665.900
06/04/2023 7,11 7,41 7,07 7,38 +3,80% 4,78% 1.805.800
05/04/2023 7,10 7,25 6,97 7,11 +0,28% 3,94% 2.371.600
04/04/2023 7,42 7,49 7,01 7,09 -4,19% 6,40% 2.379.700